Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CC-1088 in Refractory CLL
NCT00006097Phase 2Completed
- Sponsor
- Boston Medical Center
- Start
- Aug 1999
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CDC-801 in chronic lymphocytic leukemia (CLL), sponsored by Boston Medical Center. Started Aug 1999; status: completed.
02
Drugs
CDC-801
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00006097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006097.